Trials / Conditions / Norovirus
Norovirus
7 registered clinical trials studyying Norovirus — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge Wit NCT07198139 | Cocrystal Pharma, Inc. | Phase 1 / Phase 2 |
| Completed | Recombinant, Bivalent, Norovirus Vaccine Study NCT05508178 | Icon Genetics GmbH | Phase 1 |
| Completed | Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) NCT03039790 | Takeda | Phase 2 |
| Completed | Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Populatio NCT02661490 | Takeda | Phase 2 |
| Completed | Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children NCT02153112 | Takeda | Phase 2 |
| Completed | Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Vi NCT02475278 | Takeda | Phase 2 |
| Completed | Phase 1 Norwalk Vaccine Study NCT00806962 | LigoCyte Pharmaceuticals, Inc. | Phase 1 |